DynaMed vs Medwise.ai (2026)
Two clinical search products built for different health systems. DynaMed is EBSCO's disease reference, under a stated seven step evidence method with daily literature surveillance. Its Dyna AI answers only from DynaMed's own content and labels what it generates, and it is sold by subscription. Medwise.ai is a UK product from Leeds for NHS clinicians and students. It answers through selectable modes, one of which reads UK summaries of product characteristics and the drug tariff, beside articles on changes in guidance and MHRA safety updates. It is free to individual clinicians within use limits. A UK clinician held to national guidance may reasonably prefer Medwise. DynaMed brings a published security certificate and integration inside the record, and Medwise publishes neither.
- Dyna AI answers only from DynaMed's own edited content and labels what it generates.
- An ISO 27001 certificate covering DynaMed by name, downloadable from EBSCO's trust page.
- SMART on FHIR and HL7 integration for DynaMed Decisions, which reads a patient's record.
- Built for NHS clinicians, with a drug mode that reads UK product characteristics and the drug tariff.
- Terms that say plainly it is not a regulated medical device, and not for patient specific diagnosis or treatment.
- Free for individual clinicians within use limits, with a 69.99 pound App Store subscription above them.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. DynaMed and Medwise.ai are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | DynaMed | Medwise.ai |
|---|---|---|
| Primary category | Clinical Reference & Evidence | Clinical Reference & Evidence |
| Founded | Not recorded | 2019 |
| Headquarters | Ipswich, Massachusetts | Leeds, England |
| Website | dynamed.com | medwise.ai |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Point of care disease reference from EBSCO Clinical Decisions, part of EBSCO Information Services. Content rests on a stated seven step evidence based methodology with daily systematic literature surveillance, edited by a named clinical team.
Source: AI Health Index, September 2026
Clinical search and answer platform for UK clinicians and students, from Medwise AI Ltd, registered in England and Wales and based in Leeds, having started in Cambridge. Cofounded in 2019 by Dr. Keith Tsui, a doctor, and Luis Ulloa, who came from applied machine learning; the home page says it launched from the Mount Sinai Elementa Labs program.
Source: AI Health Index, September 2026
Questions buyers ask
How do DynaMed and Medwise.ai work with the EHR?
The practicing clinicians page describes DynaMed Decisions tools that surface guideline recommendations based on each patient's data. Across the product line the named methods include embedded links, search box widgets, the HL7 Infobutton context retrieval API, a web services API, single sign on and a mobile app; Infobutton is the standard built for surfacing reference content in context from inside the record.
With Medwise.ai, the platform is a standalone web application and mobile app reached by an individual clinician's own login, with NHS mail sign in as one route; that is authentication, not integration. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
How are DynaMed and Medwise.ai priced and sold?
EBSCO's DynaMed pages offer a free trial and a newsletter sign up, individual subscriptions are sold through the DynaMed site, and EBSCO has announced Dyna AI for DynaMedex individual subscribers.
For Medwise.ai, the terms of use set out two routes: open access free of charge for an individual healthcare professional or student, subject to use limits, and a paid subscription the company may require above certain thresholds or on other criteria. The company's App Store listing, a field the developer controls, shows the app as free with in app purchases and names one: Medwise AI subscription at 69.99 pounds. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
How do DynaMed and Medwise.ai handle patient data?
DynaMed Decisions takes patient data through a SMART on FHIR integration to pre populate decision aids and calculators, and that module is where retention and use questions land. Nothing published says how long queries and captured Dyna AI conversations are kept, whether they are used to train or tune any model, or what deidentification applies.
In Medwise.ai's case, the privacy notice (last updated 8 April 2025) lists conversation content and interaction data (prompts, messages, uploaded content, outputs, timestamps and metadata) among what the company collects. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
Which settings and specialties do DynaMed and Medwise.ai cover?
The family covers distinct segments: DynaMed for disease and condition reference, Dynamic Health for nursing and allied health, and DynaMedex adding Micromedex drug content for care teams and pharmacy, with DynaMed Decisions for patient specific risk tools and shared decision making. Continuing education and maintenance of certification credit accrue from use, and a clinician can affiliate with several organizations.
With Medwise.ai, the terms prohibit use by the public and by anyone under 18. The one published evaluation (JMIR Human Factors, 2025) covers acute medicine at one Welsh hospital and an earlier version of the engine, so it does not validate the current product in any setting. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Both records were reviewed on this site in September 2026. Neither has a published accuracy study of its current AI: DynaMed's study tested its search and an earlier assistant, and Medwise's pilot tested an earlier engine. DynaMed's price pages could not be read at review.
Ask both how a superseded entry is found and pulled, and how fast.